A full genome scan for late onset Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Human Molecular Genetics

• Publication date

  1999-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/8.2.237PMID 9931331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic studies on chromosome 12 in late-onset Alzheimer disease.

  1998cited by this paper
• Confirmation of an association between a polymorphism in exon 3 of the low‐density lipoprotein receptor‐related protein gene and Alzheimer's disease

  1998cited by this paper
• α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation

  1998cited by this paper
• Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation.

  1998cited by this paper
• Complete genomic screen in late-onset familial Alzheimer's disease.

  1998cited by this paper
• Initial results of a genome survey for novel Alzheimer's disease risk genes: association with a locus on the X chromosome.

  1998cited by this paper
• Alpha-2 macroglobulin is genetically associated with Alzheimer disease

  1998cited by this paper
• Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease

  1998cited by this paper
• Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene.

  1998cited by this paper
• Initial results of a genome survey for novel Alzheimer's disease risk genes: association with a locus on the X chromosome.

  1998cited by this paper
• Molecular mapping of alzheimer‐type dementia in Down's syndrome

  1998cited by this paper
• Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease

  1998cited by this paper
• Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese.

  1998cited by this paper
• Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population.

  1997cited by this paper
• Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease

  1997cited by this paper
• Presenilins and Alzheimer's disease.

  1997influential reference
• Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease

  1997cited by this paper
• α2‐Macroglobulin as a β‐Amyloid Peptide‐Binding Plasma Protein

  1997cited by this paper
• Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.

  1997cited by this paper
• Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia.

  1997cited by this paper
• Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

  1997cited by this paper
• Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease

  1997cited by this paper
• Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease.

  1997cited by this paper
• ApoE-4 and Age at Onset of Alzheimer's Disease

  1997cited by this paper
• The presenilins and Alzheimer's disease.

  1997cited by this paper
• Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease.

  1997cited by this paper
• Association studies in psychiatric genetics

  1997cited by this paper
• alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein.

  1997cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group.

  1996cited by this paper
• Genetic dissection of complex traits

  1996cited by this paper
• Presenilin-1 polymorphism and Alzheimer's disease.

  1996cited by this paper
• Presenilin-1 polymorphism and Alzheimer's disease.

  1996cited by this paper
• Affected‐sib‐pair interval mapping and exclusion for complex genetic traits: Sampling considerations

  1996cited by this paper
• Presenilin‐1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol‐associated dementia in Japanese population

  1996cited by this paper
• Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.

  1996cited by this paper
• Presenilin-1 polymorphism and Alzheimer's disease.

  1996cited by this paper
• Association between a PS‐1 intronic polymorphism and late onset Alzheimer's disease

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease

  1996cited by this paper
• Efficiency of typing unaffected relatives in an affected-sib-pair linkage study with single-locus and multiple tightly linked markers.

  1995cited by this paper
• Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease

  1995cited by this paper
• Multiple, diverse senile plaque–associated proteins are ligands of an apolipoprotein e receptor, the α2‐macroglobulin receptor/low‐density‐lipoprotein receptor—related protein

  1995cited by this paper
• APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

  1995cited by this paper
• Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results

  1995influential reference
• Genetic susceptibility to Alzheimer disease.

  1995cited by this paper
• No evidence that common allelic variation in the Amyloid Precursor Protein (APP) gene confers susceptibility to Alzheimer's disease.

  1995cited by this paper
• Candidate gene for the chromosome 1 familial Alzheimer's disease locus

  1995cited by this paper
• A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism

  1995cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995cited by this paper
• Genetic dissection of complex traits.

  1994cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Molecular genetics of Alzheimer's disease.

  1993cited by this paper
• Association and linkage: complementary strategies for complex disorders.

  1993cited by this paper
• Molecular genetics of Alzheimer’s disease

  1993cited by this paper
• Asymptotic properties of affected-sib-pair linkage analysis.

  1993cited by this paper
• MEGABASE/PKD: a genetic database for polycystic kidney disease.

  1992cited by this paper
• Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

  1992cited by this paper
• Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Genetic linkage and complex diseases, with special reference to psychiatric disorders

  1990cited by this paper
• Linkage studies in familial Alzheimer's disease.

  1989cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• The manipulator behind “Scissors”: γ -secretase and its modulators in Alzheimer’s disease

  2025cites this paper
• Amyloid-Induced Neurodegeneration: A Comprehensive Review through Aggregomics Perception of Proteins in Health and Pathology.

  2024cites this paper
• Aging and Alzheimer’s Disease

  2022cites this paper
• Translational approaches to understanding resilience to Alzheimer's disease.

  2022cites this paper
• Ageing and Alzheimer’s Disease

  2021cites this paper
• The Application of Artificial Intelligence in the Genetic Study of Alzheimer’s Disease

  2020cites this paper
• Genetics of sex differences in neuroanatomy and function.

  2020cites this paper
• Association between selected cholesterol-related gene polymorphisms and Alzheimer’s disease in a Turkish cohort

  2019cites this paper
• A candidate gene study of risk for dementia in older, postmenopausal women: Results from the Women's Health Initiative Memory Study

  2019cites this paper
• Identification of Pre-symptomatic Gene Signatures That Predict Resilience to Cognitive Decline in the Genetically Diverse AD-BXD Model

  2019cites this paper
• Genetic analysis using family-based populations

  2018cites this paper
• Genetic Risk Factors for Complex Forms of Alzheimer’s Disease

  2018cites this paper
• Deficient Wnt Signaling and Synaptic Vulnerability in Alzheimer’s Disease: Emerging Roles for the LRP6 Receptor

  2018cites this paper
• Genetics, Alzheimer’s disease and Down syndrome

  2018cites this paper
• Effects of ABCA1 R219K Polymorphism and Serum Lipid Profiles on Mild Cognitive Impairment in Type 2 Diabetes Mellitus

  2017cites this paper
• Genomic variants, genes, and pathways of Alzheimer's disease: An overview

  2017cites this paper
• Explorer Concordant Association of Insulin Degrading Enzyme Gene ( IDE ) Variants with IDE mRNA , A beta , and Alzheimer ' s Disease

  2017cites this paper
• Étude du polymorphisme rs3846662 de l’HMGCR dans le cerveau et le système périphérique

  2016cites this paper
• Oxidative stress, innate immunity, and age-related macular degeneration

  2016cites this paper
• Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective

  2016cites this paper
• Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk

  2016cites this paper
• Enfermedad de Alzheimer

  2016cites this paper
• Neuroglobin: From structure to function in health and disease.

  2016cites this paper
• The Promise of Multi-Omics and Clinical Data Integration to Identify and Target Personalized Healthcare Approaches in Autism Spectrum Disorders

  2015cites this paper
• APPENDIX VI

  2015cites this paper
• Genetic of Alzheimer’s Disease: A Narrative Review Article

  2015cites this paper
• APP Identification of APP : Gene and Protein Structure

  2014cites this paper
• Genetics of Alzheimer’s Disease

  2014cites this paper
• Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations.

  2014cites this paper
• HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer’s disease in a three cohorts study

  2014cites this paper
• Plasma insulin-degrading enzyme: Characterisation and evaluation as a potential biomarker for Alzheimer's disease

  2014cites this paper
• Cognitive Functioning in Aging Women

  2013cites this paper
• Trafficking in neurons: searching for new targets for Alzheimer's disease future therapies.

  2013cites this paper
• Vitamin D Receptor (VDR) Polymorphisms and Late-Onset Alzheimer’s Disease: An Association Study

  2013cites this paper
• Analyses post-génomiques : étude de l'implication d'IL-33 et de BIN1 dans la physiopathologie de la maladie d'Alzheimer

  2013cites this paper
• Whole Exome Analysis of Early Onset Alzheimer's Disease

  2013cites this paper
• PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer’s amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE)

  2013cites this paper
• KIAA1462, A Coronary Artery Disease Associated Gene, Is a Candidate Gene for Late Onset Alzheimer Disease in APOE Carriers

  2013cites this paper
• Genetics of Alzheimer's disease.

  2012cites this paper
• Phosphorylation of Nicastrin by SGK1 Leads to Its Degradation through Lysosomal and Proteasomal Pathways

  2012cites this paper
• Effects of ApoE4 and maternal history of dementia on hippocampal atrophy.

  2012cites this paper
• Vitamin D receptor and Alzheimer's disease: a genetic and functional study.

  2012cites this paper
• Trait, State, and Mechanism: Looking Back, Looking Forward, and Understanding Why

  2012cites this paper
• The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.

  2012cites this paper
• Tailoring of membrane proteins by alternative splicing of pre-mRNA.

  2012cites this paper
• Changes in Brain Transcripts Related to Alzheimer's Disease in a Model of HFE Hemochromatosis are not Consistent with Increased Alzheimer's Disease Risk

  2012cites this paper
• A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer's disease in a Mongolian population.

  2012cites this paper
• Genetic Risk Factors for Dementia

  2011cites this paper
• The genetics of sex differences in brain and behavior.

  2011cites this paper
• Genome scan of age‐at‐onset in the NIMH Alzheimer disease sample uncovers multiple loci, along with evidence of both genetic and sample heterogeneity

  2011cites this paper
• Multiple Insulin Degrading Enzyme Variants Alter In Vitro Reporter Gene Expression

  2011cites this paper
• Identification of genetic influences in late-onset Alzheimer's disease (LOAD)

  2011cites this paper
• Linkage to the 8p21.1 Region Including the CLU Gene in Age at Onset Stratified Alzheimer's Disease Families

  2011cites this paper
• Functional assessment of a promoter polymorphism in S100B, a putative risk variant for bipolar disorder

  2011cites this paper
• Micronutrients in the Prevention and Improvement of the Standard Therapy for Alzheimer’s Disease

  2010cites this paper
• The molecular genetics of sirtuins: association with human longevity and age-related diseases.

  2010cites this paper
• Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies

  2010cites this paper
• Advances and perspectives from genetic research: development of biological markers in Alzheimer’s disease

  2010cites this paper
• Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease.

  2010cites this paper
• Molecular genetic approaches to understanding the roles and regulation of iron in brain health and disease

  2010cites this paper
• $CYP46A1$ Functional Promoter Haplotypes Decipher Genetic Susceptibility to Alzheimer's Disease

  2010cites this paper
• Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study.

  2010cites this paper
• Neuroglobin and Alzheimer's dementia: genetic association and gene expression changes.

  2010cites this paper
• APOE epsilon4 is a high-risk factor for Alzheimer's disease in the Mongolian population.

  2010cites this paper
• Evidence for three loci modifying age‐at‐onset of Alzheimer's disease in early‐onset PSEN2 families

  2010cites this paper
• Microarray studies of genome-wide changes in brain and heart gene expression in mouse models of iron overload

  2010cites this paper
• LRP-1 variation is not associated with risk of Alzheimer's disease.

  2010cites this paper
• Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease

  2010cites this paper
• and APOE in Alzheimer's disease -T catenin gene (VR22) α Interaction between the

  2010cites this paper
• Association studies of 22 candidate SNPs with late‐onset Alzheimer's disease

  2009cites this paper
• Association between promoter polymorphisms of the nicastrin gene and sporadic Alzheimer's disease in North Chinese Han population.

  2009cites this paper
• Behavioral Genetic Investigations of Cognitive Aging

  2009cites this paper
• Association analysis of dynamin‐binding protein (DNMBP) on chromosome 10q with late onset Alzheimer's disease in a large caucasian UK sample

  2009cites this paper
• Lack of association between the polymorphisms of beta-site APP-cleaving enzyme 2 (BACE2) 5'-flanking region and sporadic Alzheimer's disease.

  2009cites this paper
• Meta-analysis of linkage studies for Alzheimer's disease--a web resource.

  2009cites this paper
• Low-density lipoprotein receptor-related protein 8 gene polymorphisms and dementia.

  2009cites this paper
• Recherche de déterminants génétiques des phénotypes associés au syndrome métabolique en population

  2009cites this paper
• Further analysis of previously implicated linkage regions for Alzheimer's disease in affected relative pairs

  2009cites this paper
• Identifikation und funktionelle Charakterisierung genetischer Risikofaktoren der Alzheimer Krankheit

  2009cites this paper
• DNMBP is genetically associated with Alzheimer dementia in the Belgian population.

  2009cites this paper
• Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals

  2009cites this paper
• Die genetische und funktionelle Bedeutung des High Temperature Requirement A1 Proteins (HtrA1) und eines HtrA1-Single Nucleotide Polymorphismus für Morbus Alzheimer

  2009cites this paper
• Genomic convergence to identify candidate genes for Alzheimer Disease on chromosome 10

  2009cites this paper
• Beyond proof of principle: new genes for Alzheimer's disease through collaboration.

  2009cites this paper
• Analysis of the nicastrin promoter rs10752637 polymorphism and its association with Alzheimer’s disease

  2009cites this paper
• Searching for susceptibility genes for psychosis in late-onset Alzheimer's disease

  2009cites this paper
• HLA-A*01 is Associated with Late Onset of Alzheimer's Disease in Italian Patients

  2009cites this paper
• Alzheimer's disease genetics current status and future perspectives.

  2009cites this paper
• Genetic variation in genes involved in Abeta-degradation in Alzheimer disease

  2009influential citation
• Identification and Functional Characterization of Genetic Risk Factors in Alzheimer´s Disease

  2009cites this paper
• F4‐01‐02: Alzheimer's disease genetics: Current status and future perspectives

  2009cites this paper
• Methodological Approaches to Study the Genetics of Dementia and Cognitive Function

  2009cites this paper
• Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease.

  2009cites this paper
• A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

  2008cites this paper
• Association studies on susceptibility genes in Alzheimer disease

  2008cites this paper
• Childhood mental ability and late-onset dementia

  2008cites this paper
• Candidate Gene Discovery Procedure after Follow-Up Confirmatory Analyses of Candidate Regions of Interests for Alzheimer’s Disease in the NIMH Sibling Dataset

  2008cites this paper
• Mitochondrial Transcription Factor A (TFAM) Gene Variation and Risk of Late-Onset Alzheimer's Disease

  2008cites this paper
• Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study.

  2008cites this paper
• Linkage and Association Study of Late‐Onset Alzheimer Disease Families Linked to 9p21.3

  2008cites this paper